IOLCP — IOL Chemicals and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹28.62bn
- IN₹27.62bn
- IN₹20.79bn
- 67
- 40
- 88
- 76
Annual balance sheet for IOL Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,660 | 1,417 | 231 | 1,428 | 2,171 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,381 | 5,141 | 5,525 | 5,263 | 5,140 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,223 | 10,808 | 9,204 | 11,198 | 11,513 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,604 | 6,625 | 8,326 | 10,214 | 11,792 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 16,101 | 19,623 | 20,221 | 22,444 | 23,821 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,906 | 5,134 | 4,563 | 5,600 | 6,099 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,497 | 5,700 | 5,144 | 6,329 | 6,944 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 12,604 | 13,923 | 15,077 | 16,115 | 16,877 |
Total Liabilities & Shareholders' Equity | 16,101 | 19,623 | 20,221 | 22,444 | 23,821 |
Total Common Shares Outstanding |